Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Imunon Inc

IMNN
0,899
0,0083 (0,93%)
Pre Mercato
Ultimo aggiornamento: 13:00:14
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/2/202514:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202514:10EDGAR2Form 8-K - Current report
27/2/202514:05GLOBEIMUNON Reports 2024 Financial Results and Provides Business..
26/2/202514:05GLOBEIMUNON Announces New Immunogenicity Data from Phase 1..
20/2/202514:30GLOBEIMUNON to Hold 2024 Financial Results and Business Update..
19/2/202522:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202514:05GLOBEIMUNON Announces Translational Data from Phase 1/2 OVATION 2..
18/2/202522:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/2/202519:50EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
10/2/202514:10EDGAR2Form 8-K - Current report
10/2/202514:05GLOBEIMUNON Appoints Douglas V. Faller, M.D., Ph.D., as Chief..
28/1/202522:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202414:05GLOBEIMUNON Announces Positive CMC Meeting with FDA for IMNN-001..
10/12/202414:05GLOBEIMUNON Announces Continued Strong Improvement in Overall..
27/11/202422:30EDGAR2Form 8-K - Current report
25/11/202414:05GLOBEIMUNON Announces Results from its End-of-Phase 2 Meeting..
14/11/202423:37EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
14/11/202418:17EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202416:00GLOBEIMUNON Presents Positive Data from Phase 2 OVATION 2..
07/11/202415:05EDGAR2Form 8-K - Current report
07/11/202415:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202414:05GLOBEIMUNON Reports Third Quarter 2024 Financial Results and..
01/11/202400:57EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
31/10/202413:30GLOBEIMUNON to Hold Third Quarter 2024 Financial Results and..
30/10/202414:05GLOBEIMUNON to Present Phase 2 Data of IMNN-001 in Treatment of..
08/10/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202414:10EDGAR2Form 8-K - Current report
07/10/202414:05GLOBEIMUNON Reports Inducement Grant Under NASDAQ Listing Rule..
27/9/202422:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/9/202422:05EDGAR2Form S-1/A - General form for registration of securities..
10/9/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202422:06GLOBEUPDATE - IMUNON’s Ovarian Cancer R&D Day to Feature..
09/9/202414:30GLOBEIMUNON’s Ovarian Cancer R&D Day to Feature Presentations..
03/9/202414:10EDGAR2Form 8-K - Current report
03/9/202413:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/8/202415:58EDGAR2Form S-1 - General form for registration of securities under..
29/8/202415:28EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/8/202414:30GLOBEIMUNON to Host R&D Day on September 18th
16/8/202414:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202414:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202415:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202414:05EDGAR2Form 8-K - Current report
14/8/202414:00GLOBEIMUNON Reports Second Quarter 2024 Financial Results and..
Apertura: Min: Max:
Chiusura: 0,8907

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network